Related Experiment Videos
Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses
1Department of Clinical Sciences, London School of Hygiene and Tropical Medicine, United Kingdom.
Abstract:
The encapsulated yeast Cryptococcus neoformans is a significant cause of opportunistic infection in patients with impaired cell-mediated immunity. The major virulence determinant of the organism is an antiphagocytic polysaccharide capsule synthesized after entry into the host. Using both an encapsulated virulent strain and an acapsular avirulent mutant, we have demonstrated the reduced ability of the encapsulated strain to stimulate specific T-cell responses in vitro. This reduction was mediated by the antiphagocytic action of the capsule rather than by direct inhibition of antigen processing and presentation, since prior opsonization with complement enhanced the ingestion of encapsulated yeast cells by purified antigen-presenting cells and allowed significant T-cell activation. Once ingestion had occurred, cryptococci were efficiently processed by activated macrophages via a chloroquine-sensitive pathway. Cryptococcal antigens were available for T-cell recognition within 1 to 2 h of interaction with macrophages and presented in a major histocompatibility complex-restricted manner. Our results suggest that the antiphagocytic action of the polysaccharide capsule is an important determinant for the development of T-cell immunity to C. neoformans.
Insights
The polysaccharide capsule of Cryptococcus neoformans hinders T-cell responses by preventing phagocytosis. This immune evasion is crucial for opportunistic infections in immunocompromised individuals.
Area of Science:
- Immunology
- Microbiology
- Infectious Diseases
Background:
- Cryptococcus neoformans is a yeast causing opportunistic infections.
- Its polysaccharide capsule is a key virulence factor, inhibiting phagocytosis.
- Impaired cell-mediated immunity increases susceptibility to cryptococcosis.
Purpose of the Study:
- To investigate how the Cryptococcus neoformans capsule affects T-cell immune responses.
- To determine if capsule's antiphagocytic property or direct inhibition impacts T-cell activation.
- To understand the role of capsule in developing T-cell immunity.
Main Methods:
- Comparison of encapsulated virulent and acapsular avirulent Cryptococcus neoformans strains.
- In vitro T-cell response assays using purified antigen-presenting cells and macrophages.
- Assessment of antigen processing and presentation via major histocompatibility complex (MHC).
Main Results:
- Encapsulated Cryptococcus neoformans showed reduced T-cell stimulation compared to the acapsular mutant.
- Antiphagocytic action of the capsule, not direct inhibition, mediated reduced T-cell responses.
- Opsonization with complement enhanced phagocytosis and T-cell activation.
- Ingested cryptococci were processed by macrophages via a chloroquine-sensitive pathway.
- Antigens were presented in an MHC-restricted manner within 1-2 hours.
Conclusions:
- The antiphagocytic nature of the Cryptococcus neoformans capsule is critical for evading T-cell immunity.
- This immune evasion mechanism contributes to the pathogenesis of cryptococcosis.
- Targeting capsule's antiphagocytic function could enhance T-cell immunity against Cryptococcus neoformans.